APA (7th ed.) Citation

Flink, D. M., Jeong, S., Thurston, G., Bannerji, R., Jankovic, V., Fiaschi, N., . . . Ambati, S. R. Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Flink, Dina M., et al. Molecular Assessment of Intratumoral Immune Cell Subsets and Potential Mechanisms of Resistance to Odronextamab, a CD20×CD3 Bispecific Antibody, in Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma. BMJ Publishing Group.

MLA (9th ed.) Citation

Flink, Dina M., et al. Molecular Assessment of Intratumoral Immune Cell Subsets and Potential Mechanisms of Resistance to Odronextamab, a CD20×CD3 Bispecific Antibody, in Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma. BMJ Publishing Group.